Certara to sell regulatory and medical writing business (CERT)
Summary
Certara (CERT) stock jumps as the company agrees to sell its regulatory & medical writing unit for up to $135M, boosting AI drug development focus. Read more he...
Description
Certara (CERT) stock jumps as the company agrees to sell its regulatory & medical writing unit for up to $135M, boosting AI drug development focus. Read more he...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source